Ad is loading...
HCPSX
Price
$83.92
Change
+$0.10 (+0.12%)
Updated
Nov 22 closing price
RYVLX
Price
$572.76
Change
+$1.69 (+0.30%)
Updated
Nov 22 closing price
Ad is loading...

HCPSX vs RYVLX

Header iconHCPSX vs RYVLX Comparison
Open Charts HCPSX vs RYVLXBanner chart's image
ProFunds UltraSector Health Care Svc
Price$83.92
Change+$0.10 (+0.12%)
VolumeN/A
CapitalizationN/A
Rydex NASDAQ-100® 2x Strategy A
Price$572.76
Change+$1.69 (+0.30%)
VolumeN/A
CapitalizationN/A
HCPSX vs RYVLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HCPSX vs. RYVLX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCPSX is a StrongBuy and RYVLX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.46B vs. HCPSX (17M). HCPSX (0.00) and RYVLX (0.00) have matching dividends . HCPSX was incepted earlier than RYVLX: HCPSX (24 years) vs RYVLX (20 years). RYVLX is a more actively managed with annual turnover of: 461.00 vs. HCPSX (77.00). RYVLX has a lower initial minimum investment than HCPSX: RYVLX (2500) vs HCPSX (15000). RYVLX annual gain was more profitable for investors over the last year : 53.22 vs. HCPSX (11.89). RYVLX return over 5 years is better than : 212.88 vs. HCPSX (48.35).
HCPSXRYVLXHCPSX / RYVLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years20 years-
Gain YTD4.71039.61912%
Front LoadN/AN/A-
Min. Initial Investment150002500600%
Min. Initial Investment IRAN/AN/A-
Net Assets17M1.46B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year11.8953.2222%
Returns for 3 years-1.9910.72-19%
Returns for 5 years48.35212.8823%
Returns for 10 years104.89655.5216%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PK14.680.48
+3.38%
Park Hotels & Resorts
VITL31.030.90
+2.99%
Vital Farms
PTC192.754.25
+2.25%
PTC
ZNTL3.180.05
+1.60%
Zentalis Pharmaceuticals
BOLT0.57N/A
-0.56%
Bolt Biotherapeutics